drugset / Trial / NCT00709865
Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the current study is to assess the safety and tolerability of intravenous tonapofylline.
Timeline
- Start
- 2008-07-31
- Primary completion
- 2009-10-30
- Completion
- 2009-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tonapofylline | Small molecule | 0.03 mg/kg | — |
| Subject | Tonapofylline | Small molecule | 0.15 mg/kg | — |
| Subject | Tonapofylline | Small molecule | 0.3 mg/kg | — |